Abstract
The secondary dystroglycanopathies are characterised by the hypoglycosylation of alpha dystroglycan, and are associated with mutations in at least 18 genes which act on the glycosylation of this cell surface receptor rather than the Dag1 gene itself. At the severe end of the disease spectrum, there are substantial structural brain defects, the most striking of which is often cobblestone lissencephaly. The aim of this study was to determine the genespecific aspects of the dystroglycanopathy brain phenotype through a detailed investigation of the structural brain defects present at birth in three mouse models of dystroglycanopathy -the FKRP KD which has an 80% reduction in Fkrp transcript levels; the Pomgnt1 null , which carries a deletion of exons 7-16 of the Pomgnt1 gene; and the Large myd mouse, which carries a deletion of exons 5-7 of the Large gene. We show a rostrocaudal and mediolateral gradient in the severity of brain lesions in FKRP KD , and to a lesser extent Pomgnt1 null mice.
Furthermore, the mislocalisation of Cajal-Retzius cells is correlated with the gradient of these lesions and the severity of the brain phenotype in these models. Overall these observations implicate gene specific differences in the pathogenesis of brain lesions in this group of disorders. 
Introduction
The dystroglycanopathies are a heterogeneous group of neuromuscular diseases, associated with mutations in genes that encode proteins implicated in the glycosylation of alpha dystroglycan rather than the Dag1 gene itself. As a consequence these are referred to as 'secondary' rather than primary. Rare mutations in the Dag1 gene have been reported but they amount to only a few cases due most likely to embryonic lethality (27) . To date, mutations in at least 18 genes have been associated with the secondary dystroglycanopathies, many of which encode either proven or putative glycosyl transferases. These include POMGNT1, which is a demonstrated glycosyltransferase adding N-acetylglucosamine (88) ; LARGE, a bifunctional glycosyltransferase that alternately transfers xylose and glucuronic acid and confers ligand binding (25, 38, 50, 79) , and Fukutinrelated protein (FKRP), the function of which is currently unknown (7, 10, 12) . Interestingly, mutations in these genes are associated with a wide spectrum of clinical phenotypes, which at the severe end of the disease spectrum include congenital muscular dystrophies with lissencephaly, which is strongly suggestive of this group of disorders (17) . In addition, patients may show cortical and cerebellar dysplasia, polymicrogyria and hydrocephalus, with evidence of dysmyelination on MRI (9) . Work in dystroglycanopathy patients and mouse models, strongly suggests that the hypoglycosylation of alpha dystroglycan is central to the pathogenesis via its effect on the structural integrity of the pial basement membrane during cortical development (56, 59) .
Dystroglycan (DG) is transcribed from a single gene (Dag1) and undergoes post-translational cleavage to produce the peripheral membrane protein alpha dystroglycan, and the transmembrane protein beta dystroglycan, which are non-covalently linked (37). Alpha dystroglycan undergoes extensive O-linked mannosylation of its central mucin-rich domain, and these glycan chains mediate binding to extracellular matrix proteins such as laminin (20) , agrin (23, 86) , neurexin (74) , pikachurin (69) and perlecan (57) . Beta dystroglycan in turn interacts with the cell's actin cytoskeleton via dystrophin, utrophin, ezrin or plectin (57) .
Together, alpha and beta dystroglycan effectively link the cytoskeleton to the extracellular matrix. The DG complex has been previously demonstrated to play a primary role in the deposition, organisation and turnover of basement membranes (31) .
Targeted deletion of dystroglycan in the brain during development, or mutations of known or putative glycosyltransferases involved in the glycosylation of alpha dystroglycan, have both been demonstrated previously to recapitulate many aspects of WWS and MEB, indicating dystroglycan as central to the disease pathogenesis (1, 25, 49, 58) . However, in the absence of comparative studies it is unclear whether some aspects of the neuropathologic lesions are gene specific. In order to answer this question, we have now undertaken a detailed investigation of the structural brain defects in three dystroglycanopathy mouse models -the FKRP-Neo Tyr307Asn (FKRP KD ) which has an 80% reduction in Fkrp transcript levels (1); the Pomgnt1 null mouse, which carries a deletion of exons 7-16 of the Pomgnt1 gene; and the Large myd mouse, which carries a deletion of exons 5-7 of the Large gene (25) .
Materials and Methods
Mouse models and Genotyping.
Three dystroglycanopathy mouse models were compared -the FKRP-Neo Tyr307Asn (FKRP   KD   ) (1); the Pomgnt1 null , and the Large myd (25 Heat-induced epitope retrieval (HIER) was performed in Tris-EDTA (10 mM Tris-HCl, 1 mM disodium EDTA, pH 8.0). All primary antibodies were diluted in phosphate buffered saline containing 0.05% tween 20 (Sigma) and 5% goat serum (Sigma), and sections were incubated for 1 hour at room temperature. Visualisation of antibody binding used the Envision™ HRP-conjugated polymer system (DAKO).
Generation of brain maps
Photomicrographs of HE stained sections were captured on a Leica DM4000B bright field microscope using a Leica DC500 camera. Using Photoshop 5 (Adobe), maps were generated to allow comparison of similar levels.
Cajal-Retzius cell counts
The number of Cajal-Retzius (CR) cells were counted at two brain levels -the rostral cortex, at the level of the corpus callosum; and the caudal cortex, at the level of the hippocampus.
To ensure consistency, levels were matched using appropriate anatomical landmarks. The number of CR cells in the cortex were counted in each section. For each mouse, three serial reelin-stained sections (5µm apart) were counted at rostral and caudal levels, and the mean Figure 1I-L) . The dentate gyrus of the hippocampus was disrupted in a subset (2/5) of FKRP KD mice (Figure 3 ). Despite reports of disruption to the hippocampus in adult Large myd and another strain of Pomgnt1 -/-mice in the literature (34, 47) , lesions were not identified in these strains at P0 in the current study.
The inferior and superior colliculi, were disrupted in all three lines of mice. Lesions in Disruption to the radial glial scaffold is present in all of the mouse models of dystroglycanopathy, but the glia limitans is most extensively disrupted in FKRP KD mice.
In wild type mice elongate BLBP-positive processes extended to the surface of the brain, where there was diffuse, continuous subpial staining of the radial glial end feet, which form the glia limitans ( Figure 5A . A, E, I, M).
In FKRP KD mice, staining in the ventricular zone was similar to that observed in wild type mice, however, radial glial processes were often haphazardly arranged, there was no subpial 21 staining (complete disruption of the glia limitans) and scattered BLBP-positive foci (radial glial processes) were present within the disorganised cortical plate and extra cortical layer. The tectum was less affected than the cortex, but significant abnormalities were still apparent.
Although relatively organised centrally and dorsomedially, discontinuous laminar staining was apparent more laterally and large numbers of heterotopic neurons and glial cells were present superficial to the glia limitans, expanding the sub arachnoid space ( Figure 5A . B, F, J, N).
In Pomgnt1 null mice, disruption to the glia limitans was still substantial, but there remained some foci of laminar staining (superficial to more organised areas of the cortical plate). In the rest of the cortex, and in the substantial extracortical layer present above these laminar foci of displaced glia limitans, were scattered BLBP-positive areas, similar to those observed in the FKRP KD (radial glial processes). In the tectum, there was relatively little disruption to the laminar architecture, but multifocally, BLBP staining was discontinuous, and neuroglial cells were seen extending through the defects and expanding the subarachnoid space
In the cortex of Large myd mice, the glia limitans was largely continuous, although separated from the arachnoid by heterotopic neurons and glial cells. Multifocally there were defects in the glia limitans, which were associated with disorganisation of the underlying cortical plate, and in these areas, neurons and glial cells were visible migrating through the defects expanding the subarachnoid space and forming a narrow extracortical layer. The glia limitans in the tectum of Large myd mice displayed multifocal discontinuities in BLBP staining associated with migration of neurons and glial cells through into the subarachnoid space to form an extracortical layer ( Figure 5A . D, H, L, P).
These findings indicate that there are substantial differences in the degree of disruption to the glia limitans between the different mouse models which correlates with the overall severity of the brain phenotype. Disruption was most pronounced in FKRP KD mice and mildest in Large myd mice. Pan laminin labelling to show the location of the glial limitans is shown in Figure 5B . 21 Figure 6 ). In addition to intense sarcolemmal staining in muscle, and fine laminar immunoreactivity at the pial basement membrane, there was intense staining of the basement membrane of blood vessels within the brain and the choroidal epithelium.
Of the dystroglycanopathy models examined, Pomgnt1 null mice showed the most pronounced, diffuse loss of IIH6 immunoreactivity. Loss of immunoreactivity was complete and all tissues examined were immunonegative.
In FKRP KD mice a small, residual amount of sarcolemmal IIH6 immunoreactivity was observed within some, but not all, muscle groups. Immunolabelling was much less intense than that seen in wild type mice stained concurrently. Muscle types which continue to exhibit some sarcolemmal staining included the tongue, masticatory and laryngeal muscles.
Interestingly, IIH6 immunoreactivity was not observed at the sarcolemma of subcutaneous muscles or extraocular muscles. Immunolabelling of the pial basement membrane and the basement membrane of the choroidal epithelium was absent.
In Large myd mice, IIH6 immunolabelling was not apparent at the pia, similar to the Pomgnt1 null and the FKRP KD mice. However, labelling of a similar distribution and intensity to that observed wild type mice was observed at the choroidal epithelium. In addition, in Large myd mice, IIH6 immunolabelling was observed in multiple other epithelial structures, including the skin, developing tooth, salivary gland, choroidal epithelium and respiratory epithelium.
Mislocalisation of Cajal-Retzius cells in mouse models of dystroglycanopathy
Cajal-Retzius cells arise early in brain development and are key to the ordered migration of neurons within the cortex. They produce reelin -an extracellular glycoprotein which has roles in neuronal migration, radial glial differentiation and providing a "stop signal" to prevent over migration of neurons (54) .
In wild type mice, Cajal-Retzius (CR) cells were present multifocally within the superficial molecular layer, orientated parallel to the surface. However, in FKRP KD mice the majority of CR cells were located around the anterior cerebral artery. Scattered CR cells were present 
Discussion
FKRP, POMGNT1 and LARGE are demonstrated or putative glycosyltransferases involved in the post-translational modification of alpha dystroglycan (7, 10, 12, 25, 50, 79, 88) . They are located within the Golgi apparatus, and are hypothesised to work sequentially, with each involved in the addition of a separate sugar moiety (11, 21, 38, 42, 88 Mice from all strains exhibited distinct patterns of lesions within the brain, which varied according to the mutation. FKRP KD and Pomgnt1 null mice exhibited a rostrocaudal gradient in the severity of brain lesions, with lesions most pronounced in the rostral cortex and progressively milder more caudally. Additionally, there were differences mediolaterally, with cortical organisation greatest towards the midline, and disruption extending laterally.
Unlike the other models examined, Large myd mice did not exhibit this gradient of lesionsdefects in the Large myd were multifocal and present throughout the brain.
Although a gradient of lesion severity has not been previously reported cases of cobblestone lissencephaly in patients, specific lesion localisation is reported in other human neuronal migration defects. Loss of function mutations in the G-protein coupled receptor 56 (GPR56) in patients is associated with the autosomal recessive brain abnormality bilateral frontoparietal polymicrogyria (BFFP), in which a neuronal migration defect is isolated to the frontal and parietal lobes of the brain (15) . A gradient of lesions is also observed in cases of classical lissencephaly. LIS1 mutations produce lesions which are more severe in the occipital lobe (posterior-predominant), whereas those produced by DCX1 mutations are more severe in the frontal lobes (anterior-predominant) (63, 67) . The mechanisms underlying the specific lesion localisation in BFFP or classical lissencephaly are unknown, although in the case of classical lissencephaly is it is believed to be due to Dcx and Lis1 having distinct, but related roles in signal transduction pathways (63) .
Previously, there has been the suggestion of a medial-lateral gradient in lesion severity in conditional dystroglycan null mice that corresponds to the time point at which dystroglycan is lost (70) . In Nestin cre-DG null mice, where there is deletion of dystroglycan from around E10.5, loss of lamination and neuroglial heterotopia extend through to the lateral cortex and pyriform lobe; whereas in GFAP cre-DG null mice, in which dystroglycan is deleted around E13.5, lesions are focal and present only in the medial cortex (70 Previously, it has been hypothesised that, as disruption to the glia limitans and neuronal migration defects are largely localised to the areas of the brain which undergo most pronounced and rapid expansion during development. In agreement with this the brain lesions in dystroglycanopathy models were reported to develop due to failure of the radial glial cells to appropriately organise the basement membrane during periods of rapid cortical expansion (60) . This idea was strengthened by data from a Pomgnt1 -/-strain, whereby the basement membrane was initially normal and was intact at E11.5, but abnormalities were apparent by E13.5 (36) . Similarly, in Nestin cre-DG null mice, in which dystroglycan was knocked out from E10.5, abnormalities in the basement membrane were first apparent at E13.5 (70).
Radial glial endfeet retraction could potentially account for the lesions observed in Large This work clearly demonstrates that there is substantial variation in the brain phenotype between mouse models of the dystroglycanopathies, indicating that a "one-model-fits-all" approach to the investigation of underlying mechanisms is not appropriate, and reiterating the importance of both careful model selection, and the use of multiple mouse models, in investigative work. Since Cajal-Retzius cells typically respond to cues originating from the meninges, our results suggest that whilst cortical defects in Large myd mice are consistent with a disturbance of the radial glial scaffold as previously reported, the more severe phenotype observed in FKRP KD and Pomgnt1 null mice imply additional defects in the meninges. Whilst the subplate was not included in the present study, it is comprised of early born neurons that are of substantial interest to the present work in that they are generated around the same time as the Cajal Retzius cells. Indeed the subplate is a highly dynamic structure the transcriptomic profile of which suggests a number of intriguing roles which change through development. Future work in this area might profit from an analysis of this heterogenous cell population (33) .
It should be noted that whilst the present paper focuses on the role of the pial basement membrane in cortical development, neuron:neuron and neuron:glial interactions also play a key role in orchestrating development of the cortex. These interactions are mediated by integrins, N-cadherin, gap junction proteins together with a number of signaling pathways some of which are downstream of reelin (72) . Future work may benefit particularly from a more detailed exploration of adhesion receptor trafficking which underlies the migration of all cells and laminin internalisation in the secondary dystroglycanopathies, the latter of which has been shown to utilize dystroglycan in cancer cells (46) . HSB and SCB designed the study and wrote the paper, HSB, JLW and MH performed the experiments and analysed the data.
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SCB gratefully acknowledges the support of the Muscular Dystrophy Association (USA) and Association contres les myopathies (AFM). HSB is supported by the Royal Veterinary College. The cerebellum in the Large myd (P) does not appear to be affected at this time point. In the Large myd (D), the olfactory lobes are again normal. In these mice the cortical hemispheres remain distinct at this level, but do exhibit disruption in lamination. E, F, G, H. Cortex around the level of the corpus callosum. The cortical plate is distinct, and overlain by the cell-poor marginal zone in wild type mice (E). In the FKRP KD (F), the cortex is completely disorganised, and the cortical plate is indistinct. The Pomgnt1null and Large myd mice (G and H, respectively) have well defined cortical plates, but these are overlain by a cell-dense, subarachnoid, extracortical layer, which is more pronounced in the Pomgnt1null mice. In Pomgnt1null mice, the lateral cortex is more disorganised than the medial cortex (fine arrow). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60 In wild type mice there are multifocal, tangentially-orientated, reelin-positive Cajal-Retzius cells which form an intermittent, single-cell layer within the marginal zone (A, B). Large numbers of CR cells are present at the hippocampus. In FKRP KD mice, there is a significant decrease in the number of reelin-positive cells at the level of the corpus callosum (C). Those present are disorganised, haphazardly orientated and predominantly clustered around the anterior cerebral artery. At the level of the hippocampus, more normally distributed and orientated CR cells appear to be associated with more ordered areas of the cortical plate (D). In the POMGnT1null mice (E) there is less clustering of the CR cells around the anterior cerebral artery. CR cells extend further laterally, although are randomly distributed within the extracortical layer. Again, CR cell distribution appears more normal at the level of the hippocampus (F). In the Large myd (G) CR cells are orientated predominantly transversely (as in the wild type) but are overlain by a narrow extracortical layer, rostrally. There is some disruption in the midline at the level of the hippocampus, in areas of fusion of opposing cortical plates (H). a-d. Higher magnification views of the cortex at the level of the corpus callosum, lateral to the interhemispheric fissure (bars represent 100µm). At the level of the corpus callosum (I) there is a statistically-significant decrease in the number of CR cells in FKRPKD (P = 0.0002) and Pomgnt1null mice (P = 0.0017), relative to wild type mice (one way ANOVA with Dunnett's multiple comparisons). This is not observed in Large myd mice (P = 0.986). At the level of the hippocampus (J) in FKRP KD there is a statistically-significant increase in the number of CR cells relative to wild type (P = 0.046) but no statistically-significant differences in the number of CR cells in either Pomgnt1null or Largemyd mice relative to wild type (P = 0.304 and P = 0.930, respectively).
